Generated by Meeveem AI
"Global pharmaceutical company pioneering innovative medicines for cardiovascular disease and cancer"
Daiichi Sankyo UK creates and supplies innovative pharmaceutical products to help the NHS deliver patient care in cardiovascular disease and oncology. With over 100 years of scientific expertise and corporate origins in Japan, the company was founded in Europe in 2006 through the merger of two established pharmaceutical companies. The company is part of a global network spanning more than 20 countries, with European headquarters in Munich and approximately 2,500 employees across 14 European countries and Canada. Daiichi Sankyo pioneers leading pharmaceuticals that have contributed to the improvement of countless lives worldwide.
250
Team Members
2006
Founded
Pharma
Sector
Hybrid
Work Environment
A world where innovative healthcare contributes to the sustainable development of society and enriches quality of life for all.
At Daiichi Sankyo, our mission is to create innovative pharmaceuticals addressing diverse medical needs to contribute to the enrichment of quality of life around the world.